Merck Life Sciences Acquires HUB Organoids
The Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced the closing of the transaction to acquire HUB Organoids Holding B.V. (HUB) following regulatory clearances and the fulfilment of other customary closing conditions. The acquisition, which closed on December 23, 2024, is a strategic step aligned with the company’s commitment to providing novel next-generation biology solutions to the life science industry, specifically by enabling wider access to HUB’s technology for more faster and more effective drug development. Terms of the deal were not disclosed.
“The use of organoids offers tremendous potential to improve the drug discovery process,” said Jean-Charles Wirth, Head of Science & Lab Solutions for the Life Science business of Merck KGaA, Darmstadt, Germany. “HUB’s advanced technology, combined with our cell culture expertise and broad portfolio, makes us a valuable resource for researchers looking to leverage the power of 3D cell culture to understand the impact of drug response earlier in the development process.”
HUB possesses the foundational patent portfolio on organoids and a robust service offering ranging from new model generation to assay development and high-throughput screening, enhancing Merck KGaA, Darmstadt, Germany´s offering of cell culture tools to academia, biotech, and pharma customers. The team of approximately 70 employees is celebrating the acquisition together at the HUB campus in Utrecht, Netherlands.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 28,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
Health Starts in the Community, Not in the Hospital
A person’s health is shaped by more than access to medical care. Factors such as income, housing, stress, social environment, and access to essential services all play an important role. That is why researchers, healthcare professionals, students, and residents are working together to reduce health inequalities and create healthier communities.
Official opening of the renovated Coimbra Square and Buurthuys at Utrecht Science Park
On Tuesday, 2 June, the renewed Coimbra Square and the new Buurthuys were officially opened at Utrecht Science Park. During a festive gathering, residents, students, staff, and partners came together to celebrate and officially open these new community spaces.
Lumox wins the NL Startup Competition at Upstream Festival
Lumox, a startup from the Utrecht innovation ecosystem, has won the NL Startup Competition at Upstream Festival in Rotterdam. Organised by the Erasmus Centre for Entrepreneurship, the competition is one of the largest startup contests in the Netherlands, bringing together promising early-stage ventures from across the country.
Fantastic atmosphere at the Utrecht Science Park during the Utrecht Marathon 2026
On Sunday, May 31, Utrecht was all about sport: the Utrecht Marathon, with the Utrecht Science Park serving as both the start and finish location, brought together thousands of enthusiastic runners and spectators.